DANIEL A. MANSFIELD, M.D.

Plain English
This study focused on creating a simple tool called the Homeless Outreach Behavioral Screen (HOBS) to help outreach workers identify homeless individuals in need of mental health support. The researchers tested this tool on 649 unsheltered individuals in Los Angeles and found that for each additional area of difficulty identified, there was an 8.7 times higher chance that the person would benefit from mental health services. This is important because it can help outreach workers recognize who needs additional support, making it easier for people experiencing homelessness to get the help they need. Who this helps: This helps homeless individuals who may require mental health services.

Plain English
This study looked at how a new type of therapy, called oncolytic immunotherapy using a virus named RP1, interacts with immune cells to enhance the effectiveness of another treatment called anti-PD-1 therapy. Researchers found that when they used RP1, tumor cells showed an increased response to immune signals, leading to higher levels of a protein called PD-L1, which is important for immune system regulation. Specifically, in tests, RP1 increased PD-L1 levels significantly alongside an immune response, suggesting that combining these therapies could better fight tumors. Who this helps: This research benefits cancer patients by potentially improving treatment options through combined therapies.

Plain English
Researchers studied how a combination of two treatments—palbociclib, a cancer drug, and a reovirus called Rt3D—can work together to boost the body's immune response against cancer. They found that this combination not only increased stress in cancer cells but also raised the production of interferon, a substance that helps the immune system fight infections and cancer, leading to higher levels of immune activation and changes in tumor cell behavior. This is important because it shows a new way to enhance cancer treatment effectiveness by combining therapies that target both cancer cells and the immune response. Who this helps: Patients with cancer looking for more effective treatment options.

Plain English
This study examined the effects of a new treatment combining oncolytic virotherapy, using a modified herpes virus called T-VEC, with a method called isolated limb perfusion (ILP) for patients with advanced melanoma and sarcoma. The results showed that 53% of all patients responded positively to the treatment, with 44% of those having sarcoma achieving significant benefits, even in cases that usually don’t respond to standard therapies. These findings are important because they suggest that this treatment not only helps shrink tumors but also boosts the immune system's ability to fight cancer. Who this helps: Patients with advanced melanoma and sarcoma, especially those who haven’t responded to other treatments.

Plain English
This study looked at how high school students and their caregivers prefer to communicate about school meal programs and tested a digital tool to improve this communication. In total, 47 students and 24 caregivers shared their thoughts, revealing that effective communication can increase students' interest in participating in school meals. This matters because better communication could lead to healthier eating habits among students, helping them make better food choices at school. Who this helps: This helps students and their families by improving how they receive information about healthy school meal options.

Plain English
This study investigated the use of a new drug called ceralasertib to treat advanced solid tumors with specific genetic issues and high levels of inflammation. Out of 67 patients treated, 8% (5 patients) had their tumors shrink significantly, while 52% (34 patients) maintained stable disease without worsening. This is important because it shows that ceralasertib can work in certain patients, especially those with certain genetic defects, and suggests a potential new treatment option for difficult-to-treat cancers. Who this helps: Patients with advanced tumors that have specific genetic defects.

Plain English
This study focused on understanding how cells from healthy and fibrotic lungs communicate with each other in idiopathic pulmonary fibrosis (IPF), a serious lung disease that significantly reduces life expectancy. Researchers grew human bronchial cells alongside lung fibroblast cells to see how their interactions changed their behavior, finding that the unhealthy fibroblasts from IPF patients led to changes in the bronchial cells that could drive disease progression, such as a decrease in cell thickness and an increase in certain signaling proteins. This research is important because it offers a more accurate model for studying IPF, which can help scientists identify potential new treatments. Who this helps: This helps patients with idiopathic pulmonary fibrosis and the doctors treating them.

Plain English
This study looked at how to improve environmental monitoring using advanced technology. The researchers proposed a new approach that combines smart, self-learning systems with different environmental monitoring tasks, like finding pollution sources and conducting search and rescue missions. They found that while the ideas are promising, most of the work has only been tested in computer simulations rather than real-life situations, highlighting the need for more practical applications. Who this helps: This benefits environmental scientists and agencies working to monitor and address pollution effectively.

Plain English
This paper studied obstructive sleep apnoea (OSA), a common sleep disorder where people's airways repeatedly get blocked during sleep. They found that OSA can lead to poor sleep quality, daytime drowsiness, and serious health problems, and recommended that patients showing signs of OSA should undergo a sleep study to confirm the diagnosis. The best treatment for OSA is a machine that helps keep airways open during sleep, but some people have trouble using it, so other options like losing weight or using dental devices may also be considered. Who this helps: This research benefits patients with sleep apnoea and their healthcare providers.

Plain English
This study looked at how participating in food assistance programs affects mental health. Overall, there was no significant link between food assistance and mental health across the research reviewed. However, it was found that these programs can significantly benefit children's mental health by reducing developmental risks. Who this helps: This helps children and their families who rely on food assistance programs.

Plain English
This study looked at the connection between sleep and mental health in elite Australian Football League athletes. Researchers found that poor sleep was linked to significant mental health issues: it predicted 51% of clinical depression, 42% of stress, and 31% of anxiety symptoms. This is important because it shows that better sleep could help improve mental health in athletes who face intense performance pressures. Who this helps: This helps athletes, coaches, and sports health professionals.

Plain English
This study looked at how using specific components of viruses can enhance cancer treatments. Researchers found that a particular artificial microRNA called amiR-4 helps a cancer-killing virus, called VSVΔ51, work better by targeting a protein that makes cancer cells resistant, leading to the destruction of both infected and nearby uninfected tumor cells. This is important because it shows a new way to combine virus therapy with other treatments to potentially improve cancer outcomes. Who this helps: This helps cancer patients and their doctors find more effective treatment options.

Plain English
The study examined how patients' sleeping positions during lab and home sleep tests (polysomnography) compared to their usual positions at home, specifically looking at those with obstructive sleep apnea (OSA). Researchers found that patients spent significantly more time sleeping on their backs (14.1% more in the lab and 7.1% more at home) during the tests than they usually do, which can lead to an overestimation of OSA severity in nearly one-third of cases. Understanding these differences is important for accurately diagnosing and treating sleep apnea, ensuring appropriate care for patients. Who this helps: Patients with sleep apnea and their healthcare providers.

Plain English
This study looked at a 43-year-old woman with a history of lung issues who developed a serious lung infection after having a tooth pulled. She had a condition that made her lungs more vulnerable, and after her dental procedure and taking probiotics, her infections worsened significantly. Treatment that involved draining the fluid and using antibiotics helped her recover, highlighting that dental work and certain supplements can lead to serious lung problems in people with existing respiratory conditions. Who this helps: This information is valuable for patients with chronic lung conditions, their doctors, and dental care providers.

Plain English
Researchers studied how well different types of masks and protective gear can safeguard healthcare workers from virus exposure, specifically in situations with high amounts of aerosolized viruses. They found that only properly fitted N95 masks offered significant protection, lowering virus exposure on the face, while other masks like surgical masks didn’t provide enough defense. Using portable HEPA filters alongside fit-tested N95 masks brought virus levels down to almost zero, showing a strong combination for safety. Who this helps: This research benefits healthcare workers who are exposed to high viral loads in clinical settings.

Plain English
This study looked at how the immune system responds to treatment in sarcoma patients who received both radiotherapy and surgery. Researchers found that certain immune markers, specifically OX40 and 4-1BB, were more common in different types of sarcoma, with the more treatment-resistant type showing higher levels of specific targets for immunotherapy. These findings suggest that selecting the right patients for immunotherapy could potentially improve treatment outcomes and that analyzing immune markers can help guide this process. Who this helps: This helps sarcoma patients who may benefit from targeted immunotherapy treatments.

Plain English
This study looked at the reasons why high school students, especially those from minority backgrounds, do or do not participate in school meal programs. Researchers talked to 47 students and 24 caregivers, finding that 77% of the students were Black. They discovered that the main barriers included the taste and quality of the food, as well as the overall lunchroom experience, highlighting the need for fresher and healthier food options. Improving school meals matters because better participation can help students eat more nutritious food, which is vital for their health. Who this helps: This helps students and their families by improving school meal programs.

Plain English
This study looked at different types of T-cells in stomach cancer (gastric cancer) to see if they can predict how long patients might survive after surgery. They found that two specific types of T-cells – CD45RO and FOXP3 – are strong indicators of cancer-specific survival. For example, patients with higher levels of these T-cells had a median survival difference from less than a year to not reached, indicating a significant improvement in survival rates. Who this helps: This research benefits cancer patients and doctors by providing better ways to predict outcomes and personalize treatment.

Plain English
This study looked at the immune environment of pancreatic neuroendocrine tumors (PanNETs) to find potential treatment targets. Researchers analyzed 207 tumor samples and identified 132 immune-related genes that could help categorize the tumors into four groups. They discovered that the MLP-1 subtype, found in 26% to 31% of the samples, has a strong immune presence but a poor outlook, indicating it might benefit from specialized immunotherapies. Who this helps: This research benefits patients with pancreatic neuroendocrine tumors, particularly those with the MLP-1 subtype.

Plain English
This study looked at how leaking masks during continuous positive airway pressure (PAP) therapy can spread the coronavirus, particularly how much virus escapes into the air and lands on surfaces. Researchers found that when there was a moderate mask leak (over 21 liters per minute), virus levels were comparable to using a vented mask, with virus detected up to nearly 4 meters away from the patient. They also discovered that using a specially designed ventilated plastic hood with a high-efficiency filter greatly reduced the amount of virus found in the area. Who this helps: This helps patients receiving PAP therapy and healthcare providers by reducing the risk of virus transmission in medical settings.

Plain English
This study looked at lymph nodes from breast cancer patients to see how they change when they have metastases, or cancer spread, compared to healthy nodes. Researchers found that nodes with cancer had fewer immune cells (B cells and T cells) and showed a shift towards processes that break down tissue instead of fighting the cancer, with about 119 out of 1,453 proteins being significantly different in those with metastasis. Understanding these changes can help in finding new ways to detect cancer spread earlier in patients. Who this helps: This helps patients and doctors by improving methods for early cancer detection.

Plain English
This study examined how rectal cancer tumors respond to a type of treatment called neoadjuvant radiotherapy and identified patterns in the immune system that impact this response. Researchers found that patient responses varied significantly, with some tumors showing a 12.4% to -47.7% change in cells, and 40 specific genes were more active in patients with poor responses compared to those who responded well. These findings are important because they highlight potential new treatment strategies that target the immune system to improve outcomes for rectal cancer patients. Who this helps: This helps patients with rectal cancer and their doctors by guiding more effective treatment plans.

Plain English
This study looked at how well melatonin helps patients with traumatic brain injuries (TBI) improve their sleep. It found that patients who reported worse sleep quality at the beginning had a much better response to melatonin treatment, with a significant improvement in their sleep scores noted. Specifically, for every one-point increase in their initial sleep score, the improvement in sleep quality was substantial. Who this helps: This helps patients with traumatic brain injuries, particularly those struggling with sleep issues.

Plain English
The study looked at how much sleep disorders like obstructive sleep apnea, insomnia, and restless legs syndrome cost Australia in 2019-2020. They found that these disorders cost the country a total of $35.4 billion, with $10 billion in direct financial costs such as healthcare and lost productivity, and $25.4 billion in nonfinancial costs like reduced well-being. This research shows that improving how we detect and treat sleep disorders can significantly reduce these high costs. Who this helps: Patients suffering from sleep disorders and healthcare providers looking for effective treatment options.

Plain English
This study looked at how patients' immune systems respond to a cancer-fighting virus when combined with common chemotherapy drugs. Researchers found that patients’ bodies still produced effective antibodies against the virus, even when treated with chemotherapy, although some drugs like gemcitabine slowed down this response a bit. This is important because it shows that using this virus therapy alongside standard cancer treatments is safe and effective, ensuring patients can receive both without compromising their immune response. Who this helps: This helps cancer patients who are receiving chemotherapy.

Plain English
This study looked at a type of ovarian cancer called ovarian clear cell carcinoma (OCCC) to understand its immune environment and how it affects patient outcomes. Researchers analyzed tissue samples from 33 patients and found that certain immune cell patterns were linked to the risk of the cancer coming back. Specifically, they discovered that in patients at high risk of recurrence, immune cells that usually attack tumors were often pushed away from the cancer cells, indicating a more suppressive immune environment. Who this helps: This research benefits patients with ovarian clear cell carcinoma by guiding personalized treatment strategies.

Plain English
This study looked at how effective a program called "Smarter Lunchrooms" was in improving school lunch habits among mostly Latinx elementary school kids. Researchers observed that, even after the intervention, students were still throwing away over half of their meals, and their fruit and fiber intake actually got worse. This is important because it shows that simply changing the lunchroom environment isn’t enough to improve eating habits in this group. Who this helps: This helps kids and school nutrition programs.

Plain English
This research looked at combining two cancer treatments: oncolytic viruses (OV) and immune checkpoint inhibitors (ICI). The study found that using these two together can create a more favorable environment for the immune system to attack tumors, which may lead to better treatment outcomes. The authors are particularly excited about upcoming results from a major study involving a specific combination of these therapies, as it could significantly improve cancer care. Who this helps: This helps cancer patients who may not respond well to current treatments.

Plain English
This study looked at how cancer-associated fibroblasts (CAFs) interact with cancer cells and influence the effectiveness of oncolytic virus therapy, a treatment that uses viruses to target cancer cells. The researchers found that when cancer cells and CAFs come into contact, CAFs start producing inflammatory signals that reduce the therapy's effectiveness. Specifically, they discovered that preventing the activation of certain signaling pathways in CAFs restored the effectiveness of the virus treatment. Who this helps: Patients undergoing oncolytic virus therapy for cancer.

Plain English
Researchers studied the presence of a protein called prostate-specific membrane antigen (PSMA) in melanoma metastases, which are cancer cells that have spread from the original melanoma tumor. They analyzed 41 samples and found that PSMA can reliably identify these metastases, achieving a sensitivity of 82.9% and specificity of 73.2%, meaning it correctly identifies cancerous cells most of the time. This discovery is important because it suggests that PSMA could be a useful tool for detecting melanoma, helping improve diagnosis and treatment strategies. Who this helps: Patients with melanoma and their doctors.

Plain English
This research looked at how certain cells, called stromal fibroblasts, help detect stress in cancer cells, which can impact the effectiveness of a type of cancer treatment using oncolytic viruses. The study found that when these fibroblasts can sense stress signals, they may hinder the oncolytic therapy, making it less effective in fighting cancer. Understanding this process is important because it could lead to better ways to improve cancer treatments. Who this helps: This helps doctors and researchers working on cancer therapies.

Plain English
This study looked at Melkersson-Rosenthal Syndrome (MRS), a rare genetic disorder that can cause facial paralysis, swelling in the face, and tongue issues. Researchers tested a gene known as SLC27A1 in 14 unrelated people with MRS but did not find any harmful genetic changes in these patients. The findings show that MRS is not the same for everyone, and more research is needed to find the gene responsible for most cases. Who this helps: This research benefits patients with Melkersson-Rosenthal Syndrome and their doctors by highlighting the need for more genetic studies.

Plain English
This study looked at whether treating moderate to severe obstructive sleep apnoea (OSA) helps improve heart health. The expert panel concluded that while treating OSA lowers blood pressure in patients with high blood pressure and might help heart function, there's still uncertainty about whether it actually reduces the risk of heart attacks or deaths. Overall, the findings highlight the need for more research to clarify the heart health benefits of OSA treatment. Who this helps: This helps patients with obstructive sleep apnoea and their doctors in understanding the potential benefits of treatment for heart health.

Plain English
This study focused on treating soft-tissue sarcoma using a combination of a special virus (GLV-1h68) and a drug that targets the immune system (PD-1 blockade). Researchers found that when the virus was used before the PD-1 treatment, it significantly reduced the chance of cancer returning locally or spreading to other parts of the body, achieving a better response in previously hard-to-treat cases. Specifically, the combination improved immune responses in the tumor environment, suggesting a promising new approach to tackling this challenging cancer. Who this helps: This benefits patients with soft-tissue sarcoma and their doctors by providing a potential new treatment option.

Plain English
This study looked at how variations in a protein called Carcino-Embryonic Antigen (CEA) affect the effectiveness of a specific cancer treatment, cibisatamab, in colorectal cancer cells grown in the lab. They found that in patient-derived cancer samples, some had high levels of CEA and responded well to the treatment, while others with low or mixed CEA levels showed resistance, meaning they did not respond well. Specifically, about 4 groups were identified: one type responded well (CEAPDOs), while another with mixed CEA expression did not respond effectively, highlighting the importance of understanding these differences to improve treatment outcomes. Who this helps: This research helps patients with colorectal cancer by identifying which groups of tumors might benefit from specific immunotherapies.

Plain English
This paper studied insomnia, a widespread sleep problem that affects people of all ages and can lead to serious health issues if not addressed. It emphasizes the importance of recognizing insomnia symptoms, often caused by stress, and points out that many people do not receive the help they need, despite its connections to poor health. The authors highlight that using self-reported questionnaires can help doctors better diagnose and treat insomnia. Who this helps: This helps patients struggling with insomnia and healthcare providers looking to improve treatment options.

Plain English
This research paper focuses on insomnia, a widespread sleep disorder affecting people of all ages. It highlights that cognitive behavioral therapy (CBT) is the best first choice for treating insomnia, and it can be supported by short-term use of medication when needed. These findings matter because effective treatments can significantly improve sleep quality and overall well-being for those suffering from insomnia. Who this helps: Patients struggling with insomnia.

Plain English
Researchers studied a type of virus called herpes simplex virus type 1 (HSV-1) to improve cancer treatments known as oncolytic immunotherapies, which target tumors while sparing normal tissue. They tested 29 different strains of HSV-1 and found one that killed tumors most effectively. With enhancements, this virus not only attacks cancer cells but also boosts the immune system's response against tumors, showing promising results in mouse models, including increased immune activity and the potential for immunological memory. Who this helps: This benefits cancer patients by making existing treatments more effective.

Plain English
The study examined how sleep disorders and lack of sleep affect road safety in Australia, highlighting that these issues were largely overlooked in the national road safety plan. Experts recommended improving driver education and laws, along with new technologies to detect drowsiness and better manage sleep disorders, to prevent accidents. These changes are crucial since they could significantly reduce the number of crashes caused by tired drivers. Who this helps: This helps drivers, their families, and road safety advocates.

Plain English
This study looked at a new treatment for non muscle-invasive bladder cancer using a virus (CAVATAK) that targets cancer cells. In a small group of 15 patients, the treatment showed promise by causing inflammation in tumors and even completely eliminating the cancer in one patient. Importantly, no serious side effects were reported, indicating that this treatment could be a safe option for bladder cancer patients. Who this helps: This benefits patients with non muscle-invasive bladder cancer.

Plain English
This study looked at how certain genetically modified viruses can help protect healthy tissues in cancer patients from damage caused by radiation therapy. Researchers found that using these modified viruses (specifically, one that boosts a protein called SOD2 and another that decreases a protein called CTGF) improved tissue health after radiation in animal tests. In fact, the combination therapy helped prevent volume loss and skin tightening in treated areas, while also not interfering with the effectiveness of the cancer treatment itself. Who this helps: This benefits cancer patients undergoing radiation therapy, especially those needing surgical reconstruction.

Plain English
This study examined how different central venous access devices perform when used in a process called extracorporeal photopheresis, which is often used to treat certain conditions. Researchers tested three types of devices: the Trifusion catheter, Vortex ports, and the TidalPort, measuring how much pressure they generated at various flow rates. They found that the Vortex dual-lumen port triggered alarms at flow rates above 60 mL/min, while the Trifusion catheter and TidalPort maintained lower pressures across flow rates from 5 to 100 mL/min, indicating that some devices may work better in clinical use. Who this helps: This research benefits healthcare providers and patients undergoing extracorporeal photopheresis by highlighting which devices might function more efficiently.

Plain English
This study looked at the use of mesenchymal stem cells from umbilical cord tissue as a potential treatment for multiple sclerosis (MS). Over a year, 20 participants received seven infusions of these stem cells, and results showed that 83.3% had inactive brain and spinal cord lesions after a year. Participants also experienced improvements in their disability scores, walking times, and quality of life. Who this helps: This research benefits patients with multiple sclerosis.

Plain English
This paper examined the disconnect between efforts to improve the lives of vulnerable populations and the ongoing problem of illicit drug production in Afghanistan. It found that many statistics about opium production, often cited by organizations like the UN, have oversimplified the issue, leading to misinformed policies that do not effectively address the root causes of drug farming. This matters because flawed data can prevent development efforts from genuinely helping communities affected by the drug trade. Who this helps: Patients and communities in Afghanistan struggling with the consequences of drug production.

Plain English
This study explored the use of a virus called Coxsackievirus A21 (CVA21) as a treatment for non-muscle invasive bladder cancer (NMIBC). Researchers found that CVA21 specifically targets cancer cells with a marker called ICAM-1, leading to effective killing of these cells, especially when used with a low dose of another drug called mitomycin-C. The results showed that the combination treatment increased the virus's effectiveness and could lead to better long-term responses in patients. Who this helps: Patients with non-muscle invasive bladder cancer looking for effective treatment options.